MeSH D003876 - atopic dermatitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| A.H. Robins Company | Cortisone | Cortisone |  | 1982-01-01 |  |  |
| Methylprednisolone | Methylprednisolone |  | 1982-01-01 |  |  | |
| Prednisolone | Prednisolone |  | 1982-01-01 |  |  | |
| Prednisone | Prednisone |  | 1982-01-01 |  |  | |
| Abbott Biotherapeutics | Methylprednisolone | A-methapred |  | 1991-02-22 |  |  |
| AbbVie | Triamcinolone | Azmacort |  | 1982-04-23 |  |  |
| Prednisolone | Pred |  | 1982-01-01 |  |  | |
| Prednisolone | Pred Mild |  | 1982-01-01 |  |  | |
| Accord Healthcare | Tacrolimus | Tacrolimus |  | 2011-08-31 |  |  |
| Alcon Research | Prednisolone, Sulfacetamide | Cetapred |  | 1993-08-06 |  |  |
| Prednisolone, Sulfacetamide | Isopto Cetapred |  | 1982-01-01 |  |  | |
| Prednisolone | Prednisolone |  | 1991-10-24 |  |  | |
| Alembic Pharmaceuticals | Nystatin, Triamcinolone | Nystatin Triamcinolone |  | 2021-03-31 |  |  |
| Betamethasone | Betamethasone |  | 2024-08-22 |  |  | |
| Triamcinolone | Triamcinolone |  | 2025-10-17 |  |  | |
| Alimera Sciences | Fluocinolone acetonide | Iluvien | 2027-08-12 | 2014-09-26 |  |  |
| Fluocinolone acetonide | Yutiq | 2027-08-12 | 2018-10-12 |  |  | |
| Alkem Laboratories | Tacrolimus | Tacrolimus |  | 2020-11-12 |  |  |
| Triamcinolone | Triamcinolone |  | 2017-12-26 |  |  |
1
2
3
4
5
6
...
16
>
Clinical Trials
Historical Success Rate
Phase 1
65%31/48
Phase 2
44%36/81
Phase 3
65%47/72
Approved: 23Overall Success rate: 19%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
11
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use